Literature DB >> 3520980

The defences of the ocular surface.

A J Bron, D V Seal.   

Abstract

Bacterial infection may be responsible for mild self-limiting disease, chronic disease or acute and devasting ocular destruction. This paper and those that follow deal with some of the clinical forms of disease which are encountered, the bacteria responsible, the mechanism of invasion and the natural defences and clinical management, including selection and delivery of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3520980

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  6 in total

1.  Histopathological findings in filtering blebs with recurrent blebitis.

Authors:  H Matsuo; G Tomita; M Araie; Y Suzuki; Y Kaji; H Obata; S Tanaka
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

Review 2.  The role of eye-associated lymphoid tissue in corneal immune protection.

Authors:  Erich Knop; Nadja Knop
Journal:  J Anat       Date:  2005-03       Impact factor: 2.610

3.  Two Potential Clinical Applications of Origami-Based Paper Devices.

Authors:  Zong-Keng Kuo; Tsui-Hsuan Chang; Yu-Shin Chen; Chao-Min Cheng; Chia-Ying Tsai
Journal:  Diagnostics (Basel)       Date:  2019-11-26

Review 4.  Oxidative Stress in the Protection and Injury of the Lacrimal Gland and the Ocular Surface: are There Perspectives for Therapeutics?

Authors:  Camila Nunes Lemos; Lilian Eslaine Costa Mendes da Silva; Jacqueline Ferreira Faustino; Marina Zilio Fantucci; Adriana de Andrade Batista Murashima; Leidiane Adriano; Monica Alves; Eduardo Melani Rocha
Journal:  Front Cell Dev Biol       Date:  2022-03-11

Review 5.  Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases.

Authors:  Rajeev K Pandey; Fu-Shin Yu; Ashok Kumar
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

Review 6.  The tear film and ocular mucins.

Authors:  Harriet J Davidson; Vanessa J Kuonen
Journal:  Vet Ophthalmol       Date:  2004 Mar-Apr       Impact factor: 1.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.